aluates Reports

$ 0.0

Automative

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-28Y13103

Global Human Immunodeficiency Virus HIV 1 Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Human Immunodeficiency Virus (HIV) Therapeutics Market Research Report 2025

Code: QYRE-Auto-28Y13103

Report

July 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ViiV Healthcare

Mylan NV

AbbVie

Merck& Co. Inc

Bristol Myers Squibb Company

Cipla Ltd

Boehringer Ingelheim GmbH

Genentech Inc

Human Immunodeficiency Virus (HIV) Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Human Immunodeficiency Virus (HIV) Therapeutics Market

The global market for Human Immunodeficiency Virus (HIV) Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Human Immunodeficiency Virus (HIV) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Immunodeficiency Virus (HIV) Therapeutics.

The Human Immunodeficiency Virus (HIV) Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Immunodeficiency Virus (HIV) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Immunodeficiency Virus (HIV) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Immunodeficiency Virus (HIV) Therapeutics Market Report

Report Metric	Details
Report Name	Human Immunodeficiency Virus (HIV) Therapeutics Market
CAGR	5%
Segment by Type	NRTIs NNRTIs Entry and Fusion Inhibitors Protease Inhibitors Integrase Inhibitors Coreceptor Antagonists
Segment by Application	Hospitals Clinics Labs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Immunodeficiency Virus (HIV) Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Immunodeficiency Virus (HIV) Therapeutics Market report?

Ans: The main players in the Human Immunodeficiency Virus (HIV) Therapeutics Market are ViiV Healthcare, Mylan, AbbVie, Merck & Co., Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Genentech, Inc., Cipla, Inc.

What are the Application segmentation covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report?

Ans: The Applications covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report are Hospitals, Clinics, Labs

What are the Type segmentation covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report?

Ans: The Types covered in the Human Immunodeficiency Virus (HIV) Therapeutics Market report are NRTIs, NNRTIs, Entry and Fusion Inhibitors, Protease Inhibitors, Integrase Inhibitors, Coreceptor Antagonists

Recommended Reports

Infectious Diseases

Pharmaceutical Services

Therapeutics & Oncology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 NRTIs

1.2.3 NNRTIs

1.2.4 Entry and Fusion Inhibitors

1.2.5 Protease Inhibitors

1.2.6 Integrase Inhibitors

1.2.7 Coreceptor Antagonists

1.3 Market by Application

1.3.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Labs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Perspective (2020-2031)

2.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Growth Trends by Region

2.2.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Dynamics

2.3.1 Human Immunodeficiency Virus (HIV) Therapeutics Industry Trends

2.3.2 Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers

2.3.3 Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges

2.3.4 Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue

3.1.1 Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Human Immunodeficiency Virus (HIV) Therapeutics Revenue

3.4 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio

3.4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2024

3.5 Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics Head office and Area Served

3.6 Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Product and Application

3.7 Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Type

4.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2026-2031)

5 Human Immunodeficiency Virus (HIV) Therapeutics Breakdown Data by Application

5.1 Global Human Immunodeficiency Virus (HIV) Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2020-2031)

6.2 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025)

6.4 North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2020-2031)

7.2 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025)

7.4 Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2020-2031)

9.2 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ViiV Healthcare

11.1.1 ViiV Healthcare Company Details

11.1.2 ViiV Healthcare Business Overview

11.1.3 ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.1.4 ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.1.5 ViiV Healthcare Recent Development

11.2 Mylan

11.2.1 Mylan Company Details

11.2.2 Mylan Business Overview

11.2.3 Mylan Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.2.4 Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.2.5 Mylan Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.3.4 AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Merck & Co., Inc.

11.4.1 Merck & Co., Inc. Company Details

11.4.2 Merck & Co., Inc. Business Overview

11.4.3 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.4.4 Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.4.5 Merck & Co., Inc. Recent Development

11.5 Bristol-Myers Squibb Company

11.5.1 Bristol-Myers Squibb Company Company Details

11.5.2 Bristol-Myers Squibb Company Business Overview

11.5.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.5.4 Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.5.5 Bristol-Myers Squibb Company Recent Development

11.6 Boehringer Ingelheim GmbH

11.6.1 Boehringer Ingelheim GmbH Company Details

11.6.2 Boehringer Ingelheim GmbH Business Overview

11.6.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.6.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.6.5 Boehringer Ingelheim GmbH Recent Development

11.7 Genentech, Inc.

11.7.1 Genentech, Inc. Company Details

11.7.2 Genentech, Inc. Business Overview

11.7.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.7.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.7.5 Genentech, Inc. Recent Development

11.8 Cipla, Inc.

11.8.1 Cipla, Inc. Company Details

11.8.2 Cipla, Inc. Business Overview

11.8.3 Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.8.4 Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.8.5 Cipla, Inc. Recent Development

11.9 Boehringer Ingelheim GmbH

11.9.1 Boehringer Ingelheim GmbH Company Details

11.9.2 Boehringer Ingelheim GmbH Business Overview

11.9.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.9.4 Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.9.5 Boehringer Ingelheim GmbH Recent Development

11.10 Genentech, Inc.

11.10.1 Genentech, Inc. Company Details

11.10.2 Genentech, Inc. Business Overview

11.10.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Introduction

11.10.4 Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

11.10.5 Genentech, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

ViiV Healthcare

Mylan NV

AbbVie

Merck& Co. Inc

Bristol Myers Squibb Company

Cipla Ltd

Boehringer Ingelheim GmbH

Genentech Inc

List of Tables

Table 1. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of NRTIs

Table 3. Key Players of NNRTIs

Table 4. Key Players of Entry and Fusion Inhibitors

Table 5. Key Players of Protease Inhibitors

Table 6. Key Players of Integrase Inhibitors

Table 7. Key Players of Coreceptor Antagonists

Table 8. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2020-2025)

Table 12. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2026-2031)

Table 14. Human Immunodeficiency Virus (HIV) Therapeutics Market Trends

Table 15. Human Immunodeficiency Virus (HIV) Therapeutics Market Drivers

Table 16. Human Immunodeficiency Virus (HIV) Therapeutics Market Challenges

Table 17. Human Immunodeficiency Virus (HIV) Therapeutics Market Restraints

Table 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players (2020-2025)

Table 20. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2024)

Table 21. Ranking of Global Top Human Immunodeficiency Virus (HIV) Therapeutics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Product and Application

Table 25. Global Key Players of Human Immunodeficiency Virus (HIV) Therapeutics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2020-2025)

Table 29. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Type (2026-2031)

Table 31. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Application (2020-2025)

Table 33. Global Human Immunodeficiency Virus (HIV) Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Human Immunodeficiency Virus (HIV) Therapeutics Revenue Market Share by Application (2026-2031)

Table 35. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 50. ViiV Healthcare Company Details

Table 51. ViiV Healthcare Business Overview

Table 52. ViiV Healthcare Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 53. ViiV Healthcare Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 54. ViiV Healthcare Recent Development

Table 55. Mylan Company Details

Table 56. Mylan Business Overview

Table 57. Mylan Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 58. Mylan Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 59. Mylan Recent Development

Table 60. AbbVie Company Details

Table 61. AbbVie Business Overview

Table 62. AbbVie Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 63. AbbVie Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 64. AbbVie Recent Development

Table 65. Merck & Co., Inc. Company Details

Table 66. Merck & Co., Inc. Business Overview

Table 67. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 68. Merck & Co., Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 69. Merck & Co., Inc. Recent Development

Table 70. Bristol-Myers Squibb Company Company Details

Table 71. Bristol-Myers Squibb Company Business Overview

Table 72. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 73. Bristol-Myers Squibb Company Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 74. Bristol-Myers Squibb Company Recent Development

Table 75. Boehringer Ingelheim GmbH Company Details

Table 76. Boehringer Ingelheim GmbH Business Overview

Table 77. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 78. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 79. Boehringer Ingelheim GmbH Recent Development

Table 80. Genentech, Inc. Company Details

Table 81. Genentech, Inc. Business Overview

Table 82. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 83. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 84. Genentech, Inc. Recent Development

Table 85. Cipla, Inc. Company Details

Table 86. Cipla, Inc. Business Overview

Table 87. Cipla, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 88. Cipla, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 89. Cipla, Inc. Recent Development

Table 90. Boehringer Ingelheim GmbH Company Details

Table 91. Boehringer Ingelheim GmbH Business Overview

Table 92. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 93. Boehringer Ingelheim GmbH Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 94. Boehringer Ingelheim GmbH Recent Development

Table 95. Genentech, Inc. Company Details

Table 96. Genentech, Inc. Business Overview

Table 97. Genentech, Inc. Human Immunodeficiency Virus (HIV) Therapeutics Product

Table 98. Genentech, Inc. Revenue in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025) & (US$ Million)

Table 99. Genentech, Inc. Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Human Immunodeficiency Virus (HIV) Therapeutics Picture

Figure 2. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. NRTIs Features

Figure 5. NNRTIs Features

Figure 6. Entry and Fusion Inhibitors Features

Figure 7. Protease Inhibitors Features

Figure 8. Integrase Inhibitors Features

Figure 9. Coreceptor Antagonists Features

Figure 10. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Application: 2024 VS 2031

Figure 12. Hospitals Case Studies

Figure 13. Clinics Case Studies

Figure 14. Labs Case Studies

Figure 15. Human Immunodeficiency Virus (HIV) Therapeutics Report Years Considered

Figure 16. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region: 2024 VS 2031

Figure 19. Global Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Players in 2024

Figure 20. Global Top Human Immunodeficiency Virus (HIV) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV) Therapeutics as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV) Therapeutics Revenue in 2024

Figure 22. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2020-2031)

Figure 24. United States Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2020-2031)

Figure 28. Germany Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Region (2020-2031)

Figure 36. China Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2020-2031)

Figure 44. Mexico Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Human Immunodeficiency Virus (HIV) Therapeutics Market Share by Country (2020-2031)

Figure 48. Turkey Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Human Immunodeficiency Virus (HIV) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. ViiV Healthcare Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 52. Mylan Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 53. AbbVie Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 54. Merck & Co., Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 56. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 57. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 58. Cipla, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 60. Genentech, Inc. Revenue Growth Rate in Human Immunodeficiency Virus (HIV) Therapeutics Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Therapy Drug Market Research Report 2025

Global HIV Antiretroviral Drug Market Research Report 2025

Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diagnostic Kit for Antibody to Human Immunodeficiency Virus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Retroviral Drugs Market Research Report 2024

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Direct acting Antiviral Drugs Market

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Infectives Market Research Report 2025

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti infectious Disease Drugs Market Research Report 2025

Global Oncolytic Virus Drug Treatment Market Research Report 2025

Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions